● GlobeNewsWireNov 9, 2026 · 16:01 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 9
MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights
Enrollment in pivotal Phase 3 oPTimize trial of once-weekly canvuparatide underway 12-week MAD (Part C, Cohort 1) data for MBX 4291, a GLP-1/GIP co-agonist prodrug for obesity designed for once-monthly dosing, on track f…
● AccesswireOct 19, 2026 · 07:00 ETEARNINGS EXPECTED BY FEB 9
Microbix Attending & Presenting at IPVS 2026
Presenting Results of Novel Product for Validation & QC of HPV Assays MISSISSAUGA, ON / ACCESS Newswire / October 19, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufact…
MBX Biosciences (NASDAQ:MBX) Shares Climb 4.1% – Time to Buy?
Shares of MBX Biosciences, Inc. (NASDAQ: MBX - Get Free Report) rose 4.1% during trading on Monday. The stock traded as high as $55.93 and last traded at $55.84. 88,613 shares were traded during mid-day trading, a declin…
● Defense WorldSep 25, 2026 · 03:23 ETEARNINGS EXPECTED BY FEB 9
MBX Biosciences, Inc. $MBX Shares Newly Bought by Bank of America Corp DE
Bank of America Corp DE bought a new position in MBX Biosciences, Inc. (NASDAQ: MBX) during a recent quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 298,927 s…
MBX Biosciences: I Should Never Have Downgraded To Hold (Rating Upgrade)
MBX Biosciences, Inc. is upgraded to Buy, driven by strong canvuparatide Phase 2 data and a clear path to Phase 3 success in hypoparathyroidism. Canvuparatide's once-weekly dosing and robust efficacy position MBX to chal…
● GlobeNewsWireSep 9, 2026 · 08:00 ETCOMPANY'S OWN WORDS
MBX Biosciences to Participate in Upcoming Investor Conferences
CARMEL, Ind., and BURLINGTON, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel…
● Defense WorldSep 8, 2026 · 04:51 ETEARNINGS EXPECTED BY FEB 9
Jupiter Topco LLC Acquires Shares of 10,300 MBX Biosciences, Inc. $MBX
Jupiter Topco LLC acquired a new position in shares of MBX Biosciences, Inc. (NASDAQ: MBX) during a recent quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The …
Expected by Feb 9. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.
Most covered today
Quiet tape today.
The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.